Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Nuvectis Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nuvectis Pharma Inc. June 13, 202496.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Nuvectis Pharma Inc. | Grant or award | +35,000 | — | — |
| Nov 5, 2025 | Nuvectis Pharma Inc. | Open-market purchase | +11,000 | $5.84 | $64,240 |
| Jun 12, 2025 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Jun 13, 2024 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Jun 16, 2023 | Nuvectis Pharma Inc. | Grant or award | +18,000 | — | — |
Questions about Matthew L. Kaplan
What boards is Matthew L. Kaplan on?
Matthew L. Kaplan sits on the board of Nuvectis Pharma Inc.
How long has Matthew L. Kaplan served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.